Nashua, NH, United States of America

Ellen Weisberg


Average Co-Inventor Count = 4.8

ph-index = 2

Forward Citations = 79(Granted Patents)


Location History:

  • Nashua, NH (US) (2014 - 2016)
  • Chelmsford, MA (US) (2021)

Company Filing History:


Years Active: 2014-2021

Loading Chart...
3 patents (USPTO):

Title: Innovations by Ellen Weisberg: Pioneering Research in AML Treatments

Introduction

Ellen Weisberg is a prominent inventor based in Nashua, NH, known for her exceptional contributions to medical research and therapeutics. With a focus on advancing treatments for acute myeloid leukemia (AML), her innovative work has garnered attention in the field and culminated in three significant patents.

Latest Patents

Ellen's latest patents showcase her commitment to tackling complex health issues. One of her notable inventions is titled "Compositions and methods for identification, assessment, prevention, and treatment of AML using USP10 biomarkers and modulators." This invention is centered on the identification of novel USP10 biomarkers and modulators, providing methods for effectively assessing, preventing, and treating AML.

Another important patent she holds involves "Fused 2-aminothiazole compounds." This application relates to therapeutic organic compounds, offering compositions that include an effective amount of a therapeutic organic compound. It also outlines methods for treating and preventing diseases through the administration of these compounds to individuals in need.

Career Highlights

Ellen Weisberg is currently associated with the Dana-Farber Cancer Institute, Inc., where she actively contributes to innovative research in cancer therapeutics. Her work is characterized by her dedication to improving patient outcomes through scientific innovation and research breakthroughs.

Collaborations

Throughout her career, Ellen has collaborated with esteemed colleagues such as Hwan Geun Choi and Taebo Sim. Their joint efforts have been instrumental in advancing research initiatives and enhancing the scope of therapeutic applications in oncology.

Conclusion

Ellen Weisberg's inventive spirit and commitment to medical science have led to notable advancements in AML treatment options. Through her significant patents and collaborative efforts, she continues to make a meaningful impact in the field of cancer research, setting the stage for future innovations that may improve patient lives.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…